plan fees (not medication costs) refunded
Yu XL, Zhou L, Deng Q, Chen XY, Tan QH, Lu HL, et al
The mean percentage change in weight at week 72 was 15.0% with 5-mg weekly doses of tirzepatide, 19.5% with 10-mg doses, and 20.9% with 15-mg doses and 3.1% with placebo
Suitable for adults with a BMI of 30 or more, or 27 or more with weight-related health issues, Wegovy resulted in an average weight loss of 15% over 68 weeks in clinical studies
Additional resources beyond Novo Nordisk If you dont qualify for the PAP, several independent support options that may help reduce your medication costs: State Pharmaceutical Assistance Programs (SPAPs): Many states offer financial help for residents who need assistance paying for prescriptions
Andrographolide, a ladanditerpene extracted from Andrographis paniculata, is a MAPK/Nrf2 pathway activator (Yang et al., 2017)